Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, I.
Right arrow Articles by Tateishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, I.
Right arrow Articles by Tateishi, J.
NEUROLOGY 1994;44:299
© 1994 American Academy of Neurology

Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene

I. Inoue, MD, T. Kitamoto, MD, K. Doh-ura, MD, H. Shii, MD, I. Goto, MD and J. Tateishi, MD

Department of Neurology (Drs. Inoue and Shii), Kokura-kinen Hospital, Kitakyusyu, and the Departments of Neurology (Drs. Inoue and Goto) and Neuropathology (Drs. Kitamoto, Doh-ura, and Tateishi), Neurological Institute, Faculty of Medicine, Kyusyu University, Fukuoka, Japan.

We report the first Japanese case of familial Creutzfeldt-Jakob disease (CJD) with the heterozygous point mutation at codon 200 of the prion protein gene. This suggests that the mutation is not race-specific. The clinical and pathologic features of this case are not different from those of sporadic CJD without point mutations. Some healthy members of the family also carry the same mutation in the autosomal dominant inheritance expression.

Address correspondence and reprint requests to Dr. Isao Inoue, Department of Neurology, Neurological Institute, Faculty of Medicine, Kyusyu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812, Japan.

Supported by the Ministry of Health and Welfare of Japan.

Received February 19, 1993. Accepted for publication in final form August 10, 1993.




This article has been cited by other articles:


Home page
NeurologyHome page
Y. Shiga, K. Miyazawa, S. Sato, R. Fukushima, S. Shibuya, Y. Sato, H. Konno, K. Doh-ura, S. Mugikura, H. Tamura, et al.
Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease
Neurology, August 10, 2004; 63(3): 443 - 449.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. L. Taratuto, P. Piccardo, E. G. Reich, S. G. Chen, G. Sevlever, M. Schultz, A. A. Luzzi, M. Rugiero, G. Abecasis, M. Endelman, et al.
Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease
Neurology, February 12, 2002; 58(3): 362 - 367.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. van Harten, W. A. van Gool, I. M. van Langen, J. M. Deekman, P. H. S. Meijerink, and H. C. Weinstein
A new mutation in the prion protein gene: A patient with dementia and white matter changes
Neurology, October 10, 2000; 55(7): 1055 - 1057.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C. E. M. Hillier and R. L. Salmon
Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?
QJM, September 1, 2000; 93(9): 617 - 631.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.